Company Filing History:
Years Active: 1999-2000
Title: Dae-sik Lim: Innovator in Genetic Research
Introduction
Dae-sik Lim is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of genetic research, particularly in the development of transgenic models for studying cellular aging and radiation sensitivity. With a total of 2 patents, his work has implications for understanding genetic disorders and cancer biology.
Latest Patents
Dae-sik Lim's latest patents include innovations related to MmRad51-deficient cells and transgenic mice. The first patent discloses MmRad51-deficient transgenic mice and mouse cells, along with MmRad51/p53-deficient transgenic mice and mouse cells. This invention also describes a method for screening proteins that can rescue the senescence phenotype in MmRad51/p53-deficient cells. The second patent focuses on Ku deficient cells and non-human transgenic animals, which comprise at least one allele of the XRCC5 gene that has been mutated by targeted disruption. The research revealed that fibroblasts derived from XRCC5 mutant embryos and mice exhibited signs of premature aging, including decreased growth and hypersensitivity to gamma radiation.
Career Highlights
Dae-sik Lim is affiliated with the M.D. Anderson Cancer Center, where he conducts his research. His work has been instrumental in advancing the understanding of genetic mutations and their effects on cellular behavior. His innovative approaches have garnered attention in the scientific community, contributing to the development of new therapeutic strategies.
Collaborations
Dae-sik Lim collaborates with notable colleagues, including Paul Hasty, to further explore the implications of his research findings. Their joint efforts aim to enhance the understanding of genetic mechanisms and their potential applications in medicine.
Conclusion
Dae-sik Lim's contributions to genetic research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in understanding genetic disorders and cancer treatment.